Published in Int J Nanomedicine on October 14, 2016
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Drug delivery and targeting. Nature (1998) 6.16
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Cytotoxicity of nanoparticles. Small (2008) 5.63
Sodium/calcium exchange: its physiological implications. Physiol Rev (1999) 5.42
Biological and clinical aspects of interleukin 6. Immunol Today (1990) 5.17
Inhibition of actin polymerization by latrunculin A. FEBS Lett (1987) 5.06
Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev (2006) 4.69
Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev (2008) 4.66
PLGA-based nanoparticles: an overview of biomedical applications. J Control Release (2012) 4.39
Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study. Biophys J (2000) 4.14
Latrunculin alters the actin-monomer subunit interface to prevent polymerization. Nat Cell Biol (2000) 3.72
Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer (1988) 3.66
The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev (1998) 3.13
Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A (2011) 2.66
Ion channels and cancer. J Membr Biol (2005) 2.56
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One (2012) 2.23
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release (2002) 2.21
Actin and microtubules in cell motility: which one is in control? Traffic (2004) 2.09
Voltage-gated ion channels and electrical excitability. Neuron (1998) 2.03
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials (2009) 1.82
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine (2009) 1.72
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials (2005) 1.69
Interleukin-6: structure-function relationships. Protein Sci (1997) 1.59
Targeting of ion channels to membrane microdomains: localization of KV channels to lipid rafts. Trends Pharmacol Sci (2004) 1.55
Regulation of cell volume in health and disease. N Engl J Med (1995) 1.46
Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum (2012) 1.46
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther (2013) 1.41
The biological properties of interleukin-1. Eur Cytokine Netw (1995) 1.36
Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem (2003) 1.31
A simple method for human peripheral blood monocyte isolation. Mem Inst Oswaldo Cruz (2000) 1.26
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine (2011) 1.26
Extracellular matrix- and cytoskeleton-dependent changes in cell shape and stiffness. Exp Cell Res (2002) 1.22
Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem (2006) 1.20
Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods (2003) 1.16
A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal Biochem (2007) 1.15
Regulation of ion channel expression. Circ Res (2004) 1.15
Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J Immunol (2004) 1.14
Interaction of epithelial ion channels with the actin-based cytoskeleton. Am J Physiol Renal Physiol (2006) 1.13
Kv1.3 potassium channels in human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2003) 1.12
Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem Biophys Res Commun (2006) 1.08
Current directions in core-shell nanoparticle design. Nanoscale (2010) 1.08
Molecular basis of leukocyte-endothelium interactions during the inflammatory response. Rev Esp Cardiol (2009) 1.05
Cell elasticity determines macrophage function. PLoS One (2012) 1.05
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine (2011) 1.02
Actin filament disruption inhibits L-type Ca(2+) channel current in cultured vascular smooth muscle cells. Am J Physiol Cell Physiol (2000) 0.96
Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. J Control Release (1998) 0.94
Actin filaments play a primary role for structural integrity and viscoelastic response in cells. Integr Biol (Camb) (2012) 0.94
Interactive threats of nanoparticles to the biological system. Immunol Lett (2013) 0.89
Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J Gen Physiol (2010) 0.89
Disruption of actin filaments increases the activity of sodium-conducting channels in human myeloid leukemia cells. Mol Biol Cell (1996) 0.89
In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol (2010) 0.88
Actin filaments regulate voltage-gated ion channels in salamander retinal ganglion cells. Neuroscience (2004) 0.88
Adsorption of plasma proteins on uncoated PLGA nanoparticles. Eur J Pharm Biopharm (2013) 0.87
Selenium nanoparticles induced membrane bio-mechanical property changes in MCF-7 cells by disturbing membrane molecules and F-actin. Bioorg Med Chem Lett (2013) 0.84
Kv1.5 in the immune system: the good, the bad, or the ugly? Front Physiol (2010) 0.81
Interaction of SiO2 nanoparticles with neuronal cells: Ionic mechanisms involved in the perturbation of calcium homeostasis. Int J Biochem Cell Biol (2015) 0.79
The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin. Mol Biol Cell (2015) 0.79
Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles. Int J Pharm (2015) 0.78
Atomic force microscopy as a tool for the investigation of living cells. Medicina (Kaunas) (2013) 0.77
Reaction of human macrophages on protein corona covered TiO₂ nanoparticles. Nanomedicine (2014) 0.76
Electrophysiology properties of voltage-gated potassium channels in rat peritoneal macrophages. Int J Clin Exp Med (2013) 0.76